Study shows diabetes drugs' potential beyond weight loss
PARIS: A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues ...
Hosted on MSN47m
NVO Stock Down as Medicare Selects Semaglutide Drugs for Price Cuts
Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular ...